Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study

<div>Patients’ quality of life and work productivity improvement at baseline (visit 1) and postbaseline visits. (a) Patients with problems in the EQ-5D-3L dimensions mobility, self-care, usual activities, pain/discomfort, and anxiety/depression at baseline, visit 2, and visit 3. (b) Mean hours missed from work due to respiratory and other problems at baseline, visit 2, and visit 3.</div>

Canadian Respiratory Journal

fig4

Figure 4

Figure 4: Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 

Figure 4 | Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 